2017
Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies
KRALICKOVA, P., J. KUHNOVA, O. SOUCEK, P. VODAREK, P. ZAK et. al.Základní údaje
Originální název
Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies
Autoři
KRALICKOVA, P. (203 Česká republika), J. KUHNOVA (203 Česká republika), O. SOUCEK (203 Česká republika), P. VODAREK (203 Česká republika), P. ZAK (203 Česká republika), M. SIMKOVIC (203 Česká republika), M. MOTYCKOVA (203 Česká republika), L. SMOLEJ (203 Česká republika), E. MALA (203 Česká republika), C. ANDRYS (203 Česká republika), J. KREJSEK (203 Česká republika) a Vojtěch THON (203 Česká republika, garant, domácí)
Vydání
Journal of Immunology Research, London, Hindawi, 2017, 2314-8861
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30102 Immunology
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 3.298
Kód RIV
RIV/00216224:14110/17:00099077
Organizační jednotka
Lékařská fakulta
UT WoS
000419035800001
Klíčová slova anglicky
Pneumococcal Capsular Polysaccharides; Natural Anti-Galactosyl; Humoral Immunodeficiencies
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 21. 3. 2018 16:27, Soňa Böhmová
Anotace
V originále
Humoral deficiencies represent a broad group of disorders. The aim of the study was to compare the levels of antibodies against pneumococcal capsular polysaccharides (anti-PCP) and natural anti-galactosyl (anti-Gal) antibodies in (1) patients with chronic lymphocytic leukaemia (CLL), (2) patients with common variable immunodeficiency (CVID), and (3) a healthy population and to explore their diagnostic and prognostic potential. Serum immunoglobulin levels and levels of anti-Gal IgG, IgA, and IgM and anti-PCP IgG and IgG2 were determined in 59 CLL patients, 30 CVID patients, and 67 healthy controls. Levels of IgG, IgA, IgM, anti-Gal IgA, anti-Gal IgM, and anti-PCP IgA were lower in CLL and CVID patients than in healthy controls. Decrease in the levels of IgA, IgM, anti-Gal IgA, and anti-PCP IgA was less pronounced in the CLL group than in the CVID group. IgA decline, anti-Gal IgA, anti-PCP IgA, and anti-PCP IgG2 were negatively correlated with CLL stage. We devise the evaluation of anti-Gal antibodies to be a routine test in humoral immunodeficiency diagnostics, even in cases of immunoglobulin substitution therapy. Significant reductions, mainly in anti-Gal IgA, IgM, and anti-PCP IgA levels, may have prognostic importance in CLL patients.